课题基金 / 基金详情

PREVENTION AND TREATMENT OF IMPOTENCE

PREVENTION AND TREATMENT OF IMPOTENCE
阳痿的预防和治疗
批准号:
6138002
负责人:
TOM F LUE
金额:
$31.26万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-01 至 2001-12-31

项目摘要

项目成果

TOM F LUE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a competitive renewal application in which the authors have found that growth hormone significantly facilitated the regeneration of nitric oxide synthase containing nerves after cavernous nerve injury in a group of young rats. The authors propose to examine and compare the response to cavernous nerve injury in a group of both young and old rats and to study the effect of growth hormone and its mediator insulin-like growth factor system on the erectile mechanism. If proved beneficial in the proposed experiments, clinical application of growth hormone or IGF could become an important preventative and therapeutic manure for neurogenic impotence in humans. The specific aims are: 1: To test the hypothesis that injury to the cavernous nerve has different effects on the nonadrenergic noncholinergic vasodilator system in young and old rats. 2: To test the hypothesis that the cellular and molecular mechanisms of impotence associated with cavernous nerve injuries are due to altered gene and protein expression of NOS, TGF, NGF, IGF, FGF and adrenoreceptor in young and old rats. 3: To test the hypothesis that growth hormone facilitates regeneration of the cavernous nerve in both young and old rats. 4: To test hypothesis that the mechanism of facilitated NANC and parasympathetic nerve regeneration by growth hormone is due to production of IGF and IGFBBPs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regenerative therapy for stress urinary incontinence and pelvic floor disorder
Regenerative therapy for stress urinary incontinence and pelvic floor disorder
Therapy for Obesity-associated Stress Urinary Incontinence
Therapy for Obesity-associated Stress Urinary Incontinence
海外基金